Although inhibition of COL11A1-induced FAO sensitized ovarian cancer cells to cisplatin treatment in vitro [64], there have been no clinical trials that use FAO inhibitors for cancer treatment yet. The gene discussed is COL11A1; the disease is ovarian cancer.